HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MK-4256

a somatostatin receptor 3 antagonist; structure in first source

Also Known As:

3-(3-(4-(4-fluorophenyl)-1H-imidazol-2-yl)-1-(1-methyl-1H-pyrazol-4-yl)- 2,3,4,9-tetrahydro-1H-pyrido(3,4-b)indol-1-yl)-5-methyl-1,2,4-oxadiazole

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Carbolines: 283
      - MK-4256: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indole Alkaloids: 200
        Carbolines: 283
        MK-4256: 1
  - 3-Ring Heterocyclic Compounds
    - Carbolines: 283
      - MK-4256: 1

Experts

1.	Bakshi, Raman K: 1 article (06/2012)
2.	Ball, Richard G: 1 article (06/2012)
3.	Bradley, Scott A: 1 article (06/2012)
4.	Chicchi, Gary G: 1 article (06/2012)
5.	Dellureficio, James: 1 article (06/2012)
6.	Dobbelaar, Peter H: 1 article (06/2012)
7.	Du, Wu: 1 article (06/2012)
8.	Eiermann, George J: 1 article (06/2012)
9.	Feng, Zhe: 1 article (06/2012)
10.	Guo, Liangqin: 1 article (06/2012)

Related Diseases

1.	Hypoglycemia (Reactive Hypoglycemia) 06/14/2012 - "As compared with glipizide, MK-4256 showed a minimal hypoglycemia risk in mice. "
2.	Type 2 Diabetes Mellitus (MODY) 06/14/2012 - "The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes."

Related Drugs and Biologics

1.	Glipizide (Glucotrol)